APN News

  • Wednesday, May, 2024| Today's Market | Current Time: 06:51:43
  • COLORS presents a once-in-a-lifetime chance to star opposite Vivian D’Sena

    Published on September 5, 2013

    Mumbai known as the City of Dreams and home to the Indian film industry (Bollywood). Everyday thousands of girls make this city their home with one common dream – to make it big in the world of entertainment…to become a superstar. But very few of those starry-eyed dreams come true as they get a chance to shine with the stars they have always dreamed of. With the aim to make this dream come true, COLORS’ popular show Madhubala – Ek Ishq Ek Junoon is launching a brand new endeavour which strives to provide aspiring actors with a unique opportunity to become a star.

    Currently, on Madhubala – Ek Ishq Ek Junoon, the storyline features Superstar RK (Vivian D’sena) being banned by the Producer’s Guild for his unprofessional behavior, owing to which all producers refuse to work with him. An angry RK decides to produce his own film with a fresh face for his venture. To zero-in on the perfect new face, the show is now stepping out of the tube to conduct auditions and encouraging aspiring actors from the across the country to send in their entries. The newbie who manages to impress Superstar RK the most will be offered a chance to star opposite him and be RK’s classic heroine.

    Madhubala- Ek Ishq Ek Junoon, the frontrunner show on COLORS has come up with this initiative encouraging new talent and giving its audience an opportunity to be part of the epic show.

    The contest invites applicants to email their audition clips along with their details – Name, Age, Address, Mobile Number, Email Address and Pictures to [email protected] before September 11, 2013. One lucky winner of the contest will get a chance star in the show as RK’s heroine for his upcoming film. The winner’s name will be announced soon in September, 2013. The promo of the contest is on air from September 04, 2013.

    Source : Lokesh Shastri

    SEE COMMENTS

    Leave a Reply